OpenVSafe by OpenVAERS
Search V-safe

ZP2-25447-75382

3 vaccinations 3 coded responses 27 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
972 / OR
Registered
2021-03-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-10
    Dose 1 — Moderna
  2. 2021-03-10
    Dose 2 — Moderna
  3. 2021-03-12
    Registered in v-safe
  4. 2021-03-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-03-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2021-03-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-03-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  9. 2021-03-17
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  10. 2021-03-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-03-31
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-07
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-04-14
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-21
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-06-09
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-11-29
    Dose 3 — Moderna
  17. 2021-11-29
    Health check-in — day 0, dose 3
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  18. 2021-11-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  19. 2021-12-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea
    Adult check-in
  20. 2021-12-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  21. 2021-12-03
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site rash — Feeling: Good · Site: Redness, Swelling, Itching
    Free text: Rash is slightly distal to injection site, about four inches by two inches, around insertion of the deltoid
    MedDRA releases: 2024-11 · check-in free text available
  22. 2021-12-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Redness, Itching · Headache
    Adult check-in
  23. 2021-12-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  24. 2021-12-06
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2021-12-13
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-12-20
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-12-27
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-01-03
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-01-10
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-02-28
    Survey response — 3 months, dose 3
    MedDRA: Pregnancy — Feeling: Good · Be unable to do your normal daily activities
    Free text: Pain related to pregnancy
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-11-29
    Survey response — 12 months, dose 3
    MedDRA: Cough, Fatigue, Nasopharyngitis, Paranasal sinus hypersecretion, Respiratory syncytial virus infection, Sinus congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Common cold, likely RSV. Cough, sinus congestion and drainage, fatigue.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-02-10Moderna
22021-03-10Moderna
32021-11-29Moderna No

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-03

Systemic reaction (other): Rash is slightly distal to injection site, about four inches by two inches, around insertion of the deltoid

Release 11 — 3 months, dose 3

2022-02-28

Symptoms: Pain related to pregnancy

Release 12 — 12 months, dose 3

2022-11-29

Symptoms: Common cold, likely RSV. Cough, sinus congestion and drainage, fatigue.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDFatigue · · ✓
SDNasopharyngitis · · ✓
SDParanasal sinus hypersecretion · · ✓
SDPregnancy · · ✓
SDRespiratory syncytial virus infection · · ✓
SDSinus congestion · · ✓
SROInjection site rash · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release